A federal jury convicted Jia Bei Zhu for distributing more than one million non-compliant COVID-19 test kits during the pandemic. Prosecutors said the scheme generated millions while deceiving regulators and consumers.
Posts published in “Pharma”
A former hair stylist says workplace disinfectant exposure during COVID-era sanitation protocols permanently damaged her lungs. Her case is now tied to a proposed workers’ compensation transparency bill in South Carolina.
Allegations emerge about Greg Folkers’ involvement in early COVID-19 communications and censorship efforts. The claims raise questions about transparency and the origins narrative.
A federal appeals court has halted a policy allowing abortion drugs to be mailed without in-person consultations. The ruling highlights safety concerns and ongoing legal disputes.
A former White House public health adviser admits she limited RFK Jr.’s access to officials. The revelation raises questions about transparency in vaccine policy debates.
A Senate hearing is reviewing internal FDA emails tied to COVID vaccine safety monitoring. Lawmakers allege warnings were overlooked during rollout.
A renewed examination of COVID-era records is keeping critical questions alive. The story highlights unresolved issues surrounding origins and accountability.
A report alleges officials ignored warning signals tied to COVID vaccines and restricted data access. The claims raise questions about transparency and oversight.
A new study links the RSV vaccine during pregnancy to increased risks of preeclampsia and other complications. Researchers say findings are preliminary but warrant further investigation.
President Trump announced a sweeping agreement with Regeneron to reduce drug prices across its portfolio. The deal also includes major US investment and new medical advancements.
The US military has ended its long-standing flu vaccine mandate for service members. The move signals a broader shift in policy and debate over medical freedom.
A federal compensation program for COVID vaccine injuries has approved only a small fraction of claims. Critics argue strict rules and deadlines prevent fair access to relief.
A growing debate over vaccines highlights deeper issues of trust in public health institutions. Experts argue transparency is key to restoring confidence.
Experts say phenylephrine, a common decongestant ingredient, does not relieve nasal congestion. Regulators are now weighing whether it should be removed from the market.
An in-depth examination of vaccine history reveals complex developments and ongoing debate. The story highlights science, policy, and public perception over time.
Elon Musk’s viral post about his vaccine reaction has fueled renewed scrutiny over COVID-19 vaccine safety. Claims from a German inquiry add to the ongoing global debate.
A federal appeals court has upheld West Virginia’s strict vaccine mandate for students. The ruling denies religious exemptions and limits online schooling as a workaround.


















